PMID-sentid	Pub_year	Sent_text	comp_official_name	comp_offset	protein_name	organism	prot_offset
30452299-7	2018	MiR-130, a putative target gene of MRPL39, displayed an inverse association with the expression of MRPL39 in GC tissues and cell lines.	mir-130	0-7	mitochondrial ribosomal protein L39	Homo sapiens	35-41
30452299-7	2018	MiR-130, a putative target gene of MRPL39, displayed an inverse association with the expression of MRPL39 in GC tissues and cell lines.	mir-130	0-7	mitochondrial ribosomal protein L39	Homo sapiens	99-105
30452299-8	2018	Moreover, a luciferase assay demonstrated a direct binding between the miR-130 and MRPL39, and the reintroduction of miR-130 abrogated the anti-tumor effect of MRPL39 on GC cells.	mir-130	71-78	mitochondrial ribosomal protein L39	Homo sapiens	160-166
30452299-8	2018	Moreover, a luciferase assay demonstrated a direct binding between the miR-130 and MRPL39, and the reintroduction of miR-130 abrogated the anti-tumor effect of MRPL39 on GC cells.	mir-130	117-124	mitochondrial ribosomal protein L39	Homo sapiens	160-166
30452299-9	2018	CONCLUSION: Taken together, these findings indicate that MRPL39 serves as a tumor suppressor by directly targeting miR-130 in GC, which suggests that it might be a novel biomarker in the diagnosis and prognosis of GC.	mir-130	115-122	mitochondrial ribosomal protein L39	Homo sapiens	57-63